Endocrine Abstracts

Introduction: Primary hyperparathyroidism (PHPT) is a state of increased bone turnover that can result in secondary osteoporosis. Antiresorptive treatment can be used to preserve bone mineral density (BMD). We compared the impact of zoledronate and denosumab on bone-related biochemical parameters.Methods: We analyzed interim data from our ongoing randomized trial on osteoporotic postmenopausal women with PHPT who are being treated with either zoledronate...

IntroductionThe incidence of primary hyperparathyroidism (PHPT) increases with age; however, the clinical presentation might change with aging. We aimed to compare the clinical presentation of older and younger patients with PHPT.MethodsWe retrospectively analyzed the biochemical status, renal involvement, and bone mineral density (BMD) of patients who were diagnosed with PHPT at our endocrine clinic from 200...